Papers using
Smad1
antibodies
Characterization of connexin31.1-deficient mice reveals impaired placental developmentAsashima Makoto et al., In In Vitro Cellular & Developmental Biology. Animal, 2006
... The primary antibodies used are as follows: anti-α-tubulin (Sigma, 1:1,000), anti-Smad1/5/8 (Santa Cruz Biotechnology, Santa Cruz, CA, 1:1,000), ... Selective antagonism by PPADS at P2X-purinoceptors in rabbit isolated blood vesselsYamada Yoshihiko et al., In The Journal of Cell Biology, 1993
... Antibodies for P-Rb, CaM, CaMKII, P-CaMKII, CN, p53, Akt, p-Akt, Smad1, and P-Smad1/5 were obtained from Cell Signaling Technology; Rb, P-NFATc1, and ...
Papers on
Smad1
An emerging role for the miR-26 family in cardiovascular disease.Feinberg et al., Boston, United States. In Trends Cardiovasc Med, 2014
Recent evidence supports a central role for the miR-26 family in cardiovascular disease by controlling critical signaling pathways, such as BMP/SMAD1 signaling, and targets relevant to endothelial cell growth, angiogenesis, and LV function post-MI.
Autoantibodies associated with diseases of the CNS: new developments and future challenges.Waters et al., Oxford, United Kingdom. In Lancet Neurol, 2011
Antibodies to components of voltage-gated potassium channel complexes (VGKCs), NMDA receptors (NMDARs), AMPA receptors (AMPARs), GABA type B receptors (GABA(B)Rs), and glycine receptors (GlyRs) can be identified in patients and are associated with various clinical presentations, such as limbic encephalitis and complex and diffuse encephalopathies.